Global News

West Pharmaceutical signs tech agreement with Amgen

Thursday, June 21, 2012 02:42 PM

West Pharmaceutical Services, a global manufacturer of components and systems for injectable drug delivery, has signed an agreement with Amgen, an independent biotech based in Thousand Oaks, Calif., to evaluate Daikyo Crystal Zenith technologies for drug containment.

More... »

XTL Biopharmaceuticals to acquire Kitov Pharmaceuticals

Thursday, June 21, 2012 12:35 PM

XTL Biopharmaceuticals, an Israel-based biopharmaceutical development company, has agreed to acquire Kitov Pharmaceuticals, an Israel-based company that researches and develops combination drug products with a focus on hypertension and pain induced by osteoarthritis.

More... »

IMS Health launches SiteOptimizer

Thursday, June 21, 2012 09:45 AM

IMS Health, a Parsippany, N.J.-based provider of information, services and technology for the healthcare industry, launched IMS SiteOptimizer, a cloud-based solution that enables clinical trial organizations to more effectively identify and assess trial site locations and recruit best-performing investigators.

More... »

IPC leads effort to clarify the genetic architecture of psoriasis

Wednesday, June 20, 2012 03:47 PM

The International Psoriasis Council (IPC) announced the publication of a report in the British Journal of Dermatology’s June edition that summarizes the IPC’s efforts to establish collaboration among leading geneticists and dermatologists to advance the understanding of the genetic basis of psoriasis.

More... »

ePharmaSolutions to acquire global patient recruitment firm Polaris BioPharma

Wednesday, June 20, 2012 03:06 PM

ePharmaSolutions, a clinical services and technology solutions provider, has acquired Polaris BioPharma Consulting, a global patient recruitment and retention firm based in Slough, U.K., to meet client demand for more "in-country" site feasibility and patient recruitment support on global clinical studies.

More... »

Seven global biopharmas form neuroscience consortium

Wednesday, June 20, 2012 02:56 PM

Seven global biopharmaceutical companies have formed the Massachusetts Neuroscience Consortium, which will fund pre-clinical neuroscience at Massachusetts academic and research institutions. Participants include Abbott, Biogen Idec, EMD Serono, Janssen Research & Development, Merck, Pfizer and Sunovion Pharmaceuticals.

More... »

Phlexglobal refocuses company as ‘The TMF Experts’

Wednesday, June 20, 2012 12:37 PM

Following 12 months of significant international expansion, Phlexglobal, the creaetor of the first commercial electronic Trial Master File (eTMF) solution, PhlexEview, has announced its new corporate repositioning as ‘The TMF Experts,’ with a brand new image and website.

More... »

Standardized trial endpoints to help health authorities tackle respiratory diseases

Wednesday, June 20, 2012 12:16 PM

Science is standardizing the way respiratory health is measured, helping to judge the effectiveness of drug treatments better than ever, according to a new report by healthcare experts GBI Research.

More... »

Biologic drugs market about to soar

Wednesday, June 20, 2012 11:29 AM

EvaluatePharma, a company providing pharmaceutical and biotechnology sector analysis and consensus forecasts, has released a report titled “Surveying Tomorrow’s BioPharma Landscape: The NASDAQ Biotech Index Up Close,” which shows that the quantity of biologic drugs on the market will likely soar by 2018.

More... »

AstraZeneca, Rigel ink worldwide license for new asthma treatment

Wednesday, June 20, 2012 11:26 AM

Biopharmaceutical companies AstraZeneca and Rigel Pharmaceuticals have signed an exclusive worldwide license agreement for the global development and commercialization of R256, Rigel's inhaled JAK inhibitor shown to inhibit IL-13 and IL-4 signaling being investigated as a treatment for moderate to severe chronic asthma. 

More... »